THE ULTIMATE GUIDE TO HYMENIDIN

Phenotypic screening in drug discovery has become revived While using the expectation of providing promising lead compounds and drug targets and enhancing the good results fee of drug approval. However, target identification continues to be An important bottleneck in phenotype-centered drug discovery. We discovered the lead compounds K542 and K405